Sign inGet started

Perret Marc Olivier

Insider CIK 1420095 · CNAT Director, 10% owner · BGMD 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-013,717,861— $00SEC↗
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-016,666,668— $00SEC↗
CNAT Conatus Pharmaceuticals In X Exercise deriv2013-07-302013-08-01385,070— $00SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2013-07-302013-08-0130,000— $030,000SEC↗
CNAT Conatus Pharmaceuticals In C Conversion2013-07-302013-08-011,258,730— $01,258,730SEC↗
CNAT Conatus Pharmaceuticals In X Exercise2013-07-302013-08-0146,675— $01,305,405SEC↗
CNAT Conatus Pharmaceuticals In S Sale2013-07-302013-08-01352$11.00 $3.9K1,305,053SEC↗
CNAT Conatus Pharmaceuticals In J Other2013-07-302013-08-0116,742$11.00 $184.2K1,321,795SEC↗
CNAT Conatus Pharmaceuticals In P Buy2013-07-302013-08-01165,525$11.00 $1.82M1,487,320SEC↗
BGMD BG Medicine, Inc. S Sale2012-04-172012-04-19200,000$6.60 $1.32M1,635,432SEC↗